Abstract:Alteration of the lung microbiome has been observed in several respiratory tract diseases. However, most previous studies were based on 16S ribosomal RNA and shotgun metagenome sequencing; the viability and functional activity of the microbiome, as well as its interaction with host immune systems, have not been well studied. To characterize the active lung microbiome and its associations with host immune response and clinical features, we applied metatranscriptome sequencing to bronchoalveolar lavage fluid (BALF) samples from 25 patients with chronic obstructive pulmonary disease (COPD) and from nine control cases without known pulmonary disease. Community structure analyses revealed three distinct microbial compositions, which were significantly correlated with bacterial biomass, human Th17 immune response, and COPD exacerbation frequency. Specifically, samples with transcriptionally active Streptococcus, Rothia, or Pseudomonas had bacterial loads 16 times higher than samples enriched for Escherichia and Ralstonia. These high-bacterial-load samples also tended to undergo a stronger Th17 immune response. Furthermore, an increased proportion of lymphocytes was found in samples with active Pseudomonas. In addition, COPD patients with active Streptococcus or Rothia infections tended to have lower rates of exacerbations than patients with active Pseudomonas and patients with lower bacterial biomass. Our results support the idea of a stratified structure of the active lung microbiome and a significant host-microbe interaction. We speculate that diverse lung microbiomes exist in the population and that their presence and activities could either influence or reflect different aspects of lung health.IMPORTANCE Recent studies of the microbiome proposed that resident microbes play a beneficial role in maintaining human health. Although lower respiratory tract disease is a leading cause of sickness and mortality, how the lung microbiome interacts with human health remains largely unknown. Here we assessed the association between the lung microbiome and host gene expression, cytokine concentration, and over 20 clinical features. Intriguingly, we found a stratified structure of the active lung microbiome which was significantly associated with bacterial biomass, lymphocyte proportion, human Th17 immune response, and COPD exacerbation frequency. These observations suggest that the microbiome plays a significant role in lung homeostasis. Not only microbial composition but also active functional elements and host immunity characteristics differed among different individuals. Such diversity may partially account for the variation in susceptibility to particular diseases.

Lower respiratory tract microbiome and lung cancer risk prediction in patients with diffuse lung parenchymal lesions

The Microbiome of Lower Respiratory Tract and Tumor Tissue in Lung Cancer Manifested As Radiological Ground-Glass Opacity

Diminishing Microbiome Richness and Distinction in the Lower Respiratory Tract of Lung Cancer Patients: A Multiple Comparative Study Design with Independent Validation.

Characterization of the lung microbiome and exploration of potential bacterial biomarkers for lung cancer

Transcriptionally Active Lung Microbiome And Its Association With Bacterial Biomass And Host Inflammatory Status

Pulmonary microbiota signatures adjacent to adenocarcinoma, squamous cell carcinoma and benign lesion

Alterations of lower respiratory tract microbiome and short-chain fatty acids in different segments in lung cancer: a multiomics analysis

Difference Of Lower Airway Microbiome In Bilateral Protected Specimen Brush Between Lung Cancer Patients With Unilateral Lobar Masses And Control Subjects

Comparative analysis of the lung microbiota in patients with respiratory infections, tuberculosis, and lung cancer: A preliminary study

Identification of microbial markers associated with lung cancer based on multi‐cohort 16 s rRNA analyses: A systematic review and meta‐analysis

Prediction of lung cancer using novel biomarkers based on microbiome profiling of bronchoalveolar lavage fluid

Analyzing lung cancer risks in patients with impaired pulmonary function through characterization of gut microbiome and metabolites

Association Studies on Gut and Lung Microbiomes in Patients with Lung Adenocarcinoma

Alteration of the gut microbiota in patients with lung cancer accompanied by chronic obstructive pulmonary diseases

Diagnostic Value of the Microbiome in the Bronchoalveolar Fluid of Patients with Lung masses and its Relationship with their Clinical Features

Specific Gut Microbiome Signature Predicts the Early-Stage Lung Cancer

Role of Respiratory System Microbiota in Development of Lung Cancer and Clinical Application

The Composition Alteration of Respiratory Microbiota in Lung Cancer

Diagnostic signatures for lung cancer by gut microbiome and urine metabolomics profiling.

Microbiome features and clinical significance in bronchoalveolar lavage fluid of patients with pneumonic-type lung cancer

The respiratory tract microbiome and its relationship to lung cancer and environmental exposures found in rural China.